VF
VTGN icon

Virtu Financial’s VistaGen Therapeutics VTGN Stock Holding History

Virtu Financial’s Portfolio VTGN Stock Details VTGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15K Buy
+66,021
New +$39.8K ﹤0.01% 1393
2026
Q1 		– Sell
-37,739
Closed -$25K – 2359
2025
Q4 		$25K Buy
+37,739
New +$136K ﹤0.01% 1394
2025
Q3 		– Sell
-22,946
Closed -$46K – 2139
2025
Q2 		$46K Buy
+22,946
New +$52.1K ﹤0.01% 1154
2024
Q4 		– Sell
-20,210
Closed -$61K – 2099
2024
Q3 		$61K Buy
20,210
+4,722
+30% +$16.1K ﹤0.01% 983
2024
Q2 		$54K Buy
+15,488
New +$67.1K ﹤0.01% 895
2024
Q1 		– Sell
-15,524
Closed -$80K – 2153
2023
Q4 		$80K Buy
+15,524
New +$58.7K 0.01% 1075
2022
Q4 		– Sell
-7,691
Closed -$35K – 2182
2022
Q3 		$35K Buy
+7,691
New +$76.2K ﹤0.01% 1283
2022
Q2 		– Sell
-406
Closed -$15K – 2120
2022
Q1 		$15K Sell
406
-278
-41% -$12.1K ﹤0.01% 1337
2021
Q4 		$40K Buy
+684
New +$44.5K ﹤0.01% 1390
2021
Q2 		– Sell
-2,071
Closed -$132K – 2120
2021
Q1 		$132K Buy
+2,071
New +$138K 0.01% 1229
2019
Q4 		$11K Sell
528
-1,511
-74% -$38.2K ﹤0.01% 1363
2019
Q3 		$65K Buy
+2,039
New +$45.4K 0.01% 1158

Other funds holding VTGN

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
CWS
Confluence Wealth Services Mcmurray, Pennsylvania $3.5B AUM 22.08% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
RS
R Squared Central, Hong Kong $190M AUM 25.89% 1-Year Est. Return

Virtu Financial's VTGN Position: Q2 2026 in Review

Virtu Financial opened a new position in VistaGen Therapeutics (VTGN) in Q2 2026: 66,021 shares worth $15K. The stake represents ﹤0.01% of the portfolio and ranks #1393 among its holdings. This is a return to the name: Virtu Financial previously reported a position in VTGN as recently as Q4 2025.

Virtu Financial first reported a position in VTGN in Q3 2019 and has held it in 12 quarters since. The position peaked at $132K in Q1 2021. 25 funds tracked by Wall St. Rank hold VTGN as of Q2 2026.

  • Virtu Financial held 66,021 shares of VistaGen Therapeutics worth $15K as of Q2 2026.
  • VistaGen Therapeutics was a new Virtu Financial position in Q2 2026.
  • VistaGen Therapeutics made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1393 holding.
  • Virtu Financial first reported a position in VistaGen Therapeutics in Q3 2019 and has held it in 12 quarters since.
  • Virtu Financial's VistaGen Therapeutics position peaked at $132K in Q1 2021.
  • 25 funds tracked by Wall St. Rank held VistaGen Therapeutics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.